Metabolic Profiling of Hematopoietic Stem Cells in Clonal Hematopoiesis (CHIP)
Metabolic Profiling of Hematopoietic Stem Cells in Clonal Hematopoiesis (CHIP): a Prospective Observational Study
Imelda Hospital, Bonheiden
24 participants
Feb 11, 2022
OBSERVATIONAL
Conditions
Summary
Bone marrow samples will be collected from patients undergoing hip arthroplasty surgery. Blood and bone marrow samples will be used for metabolic profiling and analysis of relevant CHIP mutations. Combined single-cell transcriptomics and mutation-specific single-cell genotyping (biotin-PCR using mutation-targeted primers followed by sequencing) will subsequently be performed. The gene expression profile of wildtype and mutant hematopoietic stem cells will be compared, performing both broad gene set enrichment analysis and targeted analysis of metabolic pathways.
Eligibility
Inclusion Criteria1
- Age 65 years and older
Exclusion Criteria2
- known haematological condition (myelodysplasia, leukemia, cancer)
- inability to provide written informed consent
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Collection of blood and bone marrow
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05246813